1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Lu, S; Tang, X; Wu, J; Xu, G; Xu, Y; Zhi, F | 1 |
1 other study(ies) available for 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and Neoplasms
| Article | Year |
|---|---|
Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; K562 Cells; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Phenethylamines; Verapamil; Vinblastine | 2012 |